These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7998906)

  • 1. Rules governing peptide-class II MHC molecule interactions.
    Hammer J; Nagy ZA; Sinigaglia F
    Behring Inst Mitt; 1994 Jul; (94):124-32. PubMed ID: 7998906
    [No Abstract]   [Full Text] [Related]  

  • 2. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
    Wu S; Gorski J; Eckels DD; Newton-Nash DK
    J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing ABRA protein peptide to fit into the HLA-DRbeta1*0301 molecule renders it protection-inducing.
    Salazar LM; Alba MP; Curtidor H; Bermúdez A; Luis E Vargas ; Rivera ZJ; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Sep; 322(1):119-25. PubMed ID: 15313182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of soluble MHC class II proteins with covalently bound single peptides.
    Kozono H; White J; Clements J; Marrack P; Kappler J
    Nature; 1994 May; 369(6476):151-4. PubMed ID: 8177320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of allorecognition by use of synthetic peptides.
    Colovai AI; Renna-Molajoni E; Cocciolo PL; Tugulea S; Liu Z; Harris PE; Suciu-Foca N; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3029-31. PubMed ID: 8962175
    [No Abstract]   [Full Text] [Related]  

  • 8. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions.
    Androulakis IP; Nayak NN; Ierapetritou MG; Monos DS; Floudas CA
    Proteins; 1997 Sep; 29(1):87-102. PubMed ID: 9294869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells.
    Hansen BE; Andersson EC; Madsen LS; Engberg J; Søndergaard L; Svejgaard A; Fugger L
    Tissue Antigens; 1998 Feb; 51(2):119-28. PubMed ID: 9510368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices.
    Sturniolo T; Bono E; Ding J; Raddrizzani L; Tuereci O; Sahin U; Braxenthaler M; Gallazzi F; Protti MP; Sinigaglia F; Hammer J
    Nat Biotechnol; 1999 Jun; 17(6):555-61. PubMed ID: 10385319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
    Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
    EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis.
    Dimitrov I; Garnev P; Flower DR; Doytchinova I
    Eur J Med Chem; 2010 Jan; 45(1):236-43. PubMed ID: 19896246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
    Soos JM; Johnson HM
    Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion.
    Patarroyo ME; Bermúdez A; Salazar LM; Espejo F
    Biochimie; 2006 Jul; 88(7):775-84. PubMed ID: 16483708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen.
    De Palma R; Wu S; Sallusto F; Di Felice G; Martucci P; Geraci D; Colombo P; Troise C; Sacerdoti G; Nocera A; Gorski J
    J Immunol; 1999 Feb; 162(4):1982-7. PubMed ID: 9973468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mannose 6-phosphate-containing N-linked glycopeptide derived from lysosomal acid lipase is bound to MHC class II in B lymphoblastoid cell lines.
    Dustin ML; McCourt DW; Kornfeld S
    J Immunol; 1996 Mar; 156(5):1841-7. PubMed ID: 8596035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses.
    Wu S; Maslanka K; Gorski J
    J Immunol; 1997 Apr; 158(7):3221-6. PubMed ID: 9120277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
    Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
    Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.